Skip to main content
Premium Trial:

Request an Annual Quote

Thanks to Today’s PIs

Premium


Genome Technology extends its sincere thanks to the leaders who generously took the time to recommend the up-and-coming investigators profiled in this special issue. We’re delighted to have such a noteworthy group of scientists to point us in the right direction.

Peter Ahnert, University of Leipzig

Phil Andrews, University of Michigan

Andrea Califano, Columbia University

Steven Carr, Broad Institute

Evan Eichler, University of Washington

Claire Fraser-Liggett, The Institute for Genomic Research

Skip Garner, UT Southwestern Medical Center

Gary Gilliland, Harvard University

Jenny Graves, The Australian National University

Eric Green, National Human Genome Research Institute

William Hahn, Dana-Farber Cancer Institute

Jonathan Haines, Vanderbilt University

David Haussler, University of California, Santa Cruz

Ole Nørregaard Jensen, University of Southern Denmark

Hiroaki Kitano, Systems Biology Institute

Alan Krensky, Stanford Medical School

Raju Kucherlapati, Harvard Partners Center for Genetics and Genomics

Harris Lewin, University of Illinois at Urbana-Champaign

Rob Martienssen, Cold Spring Harbor Laboratory

Deirdre Meldrum, University of Washington

Bud Mishra, New York University

David Muddiman, North Carolina State University

Gene Myers, HHMI’s Janelia Farm

Gene Robinson, University of Illinois at Urbana-Champaign

Bruce Roe, University of Oklahoma

David Sabatini, Whitehead Institute

Phil Sharp, Massachusetts Institute of Technology

Muhammad Soheil, University of Oxford

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.